TerminatedPhase 4

Comparison of Albuterol for Status Asthmaticus

Stopped: Study Drug Backorder

United States8 participantsStarted 2018-09-10

Plain-language summary

This study is designed to compare the length of continuous albuterol administration between two different albuterol formulations, BAC containing albuterol versus preservative free albuterol.

Who can participate

Age range5 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients will be included in the study if they are admitted to the 5th floor of Norton Children's Hospital for the treatment of an acute asthma exacerbation, initiated on continuous albuterol inhalation therapy, and are between 5 and 17 years of age. Exclusion Criteria: * Patients will be excluded from the study if they are transferred from the 5th floor to the Pediatric Intensive Care Unit (PICU), admitted for any indication other than acute asthma exacerbation, or removed from the inpatient asthma protocol for any given reason.

What they're measuring

Albuterol Administration

Timeframe: Hours until discontinuation of therapy, an average of 72 hours

Trial details

NCT IDNCT02966184

SponsorNorton Healthcare

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-10-25

Results submitted2020-09-11

View on ClinicalTrials.gov More Status Asthmaticus trials